Clinical Trials Directory

Trials / Unknown

UnknownNCT05534334

Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.

Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Gingival Pyogenic granuloma in the esthetic zone represents an esthetic problem. While surgical treatment may not give the premium esthetic demands, corticosteroid may acheive this balance.

Detailed description

In our practice, the investigators have found the use of topical steroids effectively induced regression of PGs. This protocol has been suggested by published case reports supported by the anti-inflammatory actions corticosteroid. This is a particularly valuable approach for patients who have PG in the esthetic zone allowing the surgeon to keep maximum amount of periodontal tissues.

Conditions

Interventions

TypeNameDescription
DRUGSolu-CortefA vial sol. used for intra-mascular injection

Timeline

Start date
2022-05-01
Primary completion
2022-11-29
Completion
2022-11-29
First posted
2022-09-09
Last updated
2022-09-14

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05534334. Inclusion in this directory is not an endorsement.

Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone. (NCT05534334) · Clinical Trials Directory